Clinical and Neuropsychological Investigations in Batten Disease
Status: | Recruiting |
---|---|
Conditions: | Neurology |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | Any |
Updated: | 2/7/2019 |
Start Date: | August 2004 |
End Date: | July 2025 |
Contact: | Amy Vierhile, RN PNP |
Email: | amy_vierhile@urmc.rochester.edu |
Phone: | (585)275-4762 |
This study aims to assess the natural history of Batten disease (Neuronal Ceroid
Lipofuscinosis) by obtaining information about the motor, behavioral, and functional
capabilities of individuals with Batten disease. This study will also refine and validate the
Unified Batten Disease Rating Scale (UBDRS) as a clinical rating instrument for Batten
disease.
Lipofuscinosis) by obtaining information about the motor, behavioral, and functional
capabilities of individuals with Batten disease. This study will also refine and validate the
Unified Batten Disease Rating Scale (UBDRS) as a clinical rating instrument for Batten
disease.
Batten Disease is an inherited disorder that causes progressive cognitive and behavioral
decline in children. There have been no systematic clinical studies of Batten Disease using
standardized rating instruments with known inter-rater reliability and validity.
The Batten Study Group developed the Unified Batten Disease Rating Scale (UBDRS), a clinical
rating instrument used to assess the motor, behavioral, and functional capabilities of
individuals with Batten disease. Using the UBDRS, study investigators will evaluate
participants approximately every year to track disease progression. The UBDRS is the primary
natural history tool, but the study also includes neuropsychological assessment, adaptive
function, quality of life measures, and other measures to assess the impact of Batten
Disease. Participants will be examined at the University of Rochester Batten Center, Batten
Disease Support and Research Association annual meeting, or remotely via televideo.
Information related to racial and ethnic background, medical history, symptoms, medications,
and diagnostic testing will be collected.
decline in children. There have been no systematic clinical studies of Batten Disease using
standardized rating instruments with known inter-rater reliability and validity.
The Batten Study Group developed the Unified Batten Disease Rating Scale (UBDRS), a clinical
rating instrument used to assess the motor, behavioral, and functional capabilities of
individuals with Batten disease. Using the UBDRS, study investigators will evaluate
participants approximately every year to track disease progression. The UBDRS is the primary
natural history tool, but the study also includes neuropsychological assessment, adaptive
function, quality of life measures, and other measures to assess the impact of Batten
Disease. Participants will be examined at the University of Rochester Batten Center, Batten
Disease Support and Research Association annual meeting, or remotely via televideo.
Information related to racial and ethnic background, medical history, symptoms, medications,
and diagnostic testing will be collected.
Inclusion Criteria:
- child or adult with any form of Batten disease
- parent or legal guardian of a child or adult with any form of Batten disease
Exclusion Criteria:
- parent or guardian unable or unwilling to provide permission for the affected individual
We found this trial at
1
site
60 Crittenden Blvd # 70
Rochester, New York 14642
Rochester, New York 14642
(585) 275-2121
Phone: 585-275-4762
University of Rochester The University of Rochester is one of the country's top-tier research universities....
Click here to add this to my saved trials